{
    "code": "52026484",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026484",
    "time": "2022-03-25 03:16:54",
    "許可證字號": "衛部藥輸字第026484號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/03\/19",
    "發證\/登錄日期": "104\/03\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202648401",
    "中文品名": "亞伯杉注射劑",
    "英文品名": "Abraxane for Injectable Suspension",
    "適應症": "轉移性乳癌\r\nABRAXANE用於以合併化療治療轉移疾病失敗之乳癌。除非臨床上禁用，否則先前治療應包含一種anthracycline。\r\n非小細胞肺癌\r\n對於無法手術或放射治療的患者，ABRAXANE併用carboplatin，做為局部晚期或轉移性非小細胞肺癌之第一線治療。\r\n胰腺癌\r\nABRAXANE合併gemcitabine，做為轉移性胰腺癌患者之第一線治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "一百支以下盒裝 100毫克玻璃小瓶裝 stopper材質變更為20 mm, gray chlorobutyl rubber stopper玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/03\/19",
    "主成分略述": "PACLITAXEL",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "620117G076  賽基有限公司",
    "申請商地址": "臺北市松山區健康路156號5樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1437920200  臺灣神隆股份有限公司",
            "製造廠廠址": "台南市善化區台南科學園區南科八路１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FDE0565000  BAXTER ONCOLOGY GMBH",
            "製造廠廠址": "KANTSTRASSE 2, 33790 HALLE\/WESTFALEN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FIT0119000  INDENA S.P.A.",
            "製造廠廠址": "VIA DON MINZONI 6, 20090 SETTALA (MILANO) ITALY",
            "製造廠公司地址": "20139 MILANO-V.LE ORTLES 12,ITALY",
            "製造廠國別": "ITALY",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FSG0036100  BOLLORE LOGISTICS SINGAPORE PTE LTD",
            "製造廠廠址": "101 ALPS AVENUE #03-01 SINGAPORE 498793",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "貼標廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000100",
            "成分名稱": "PACLITAXEL",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "30 x 55 (+\/-1) mm 小瓶裝",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Abraxane Images (2017Aug01)-106-08-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026484&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "1. Abraxane TW PIL_version 12_2019_20200920-20210610(TFDA Clean)TL_reviewer checked-0629-110-07-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026484&Seq=005&Type=9"
        },
        {
            "title": "外盒-貼標廠更新_20210713-110-07-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026484&Seq=003&Type=8"
        }
    ]
}